Clinical Features of Fatal Asthma  by Chen, Chiung-Zuei et al.
Fatal asthma
Kaohsiung J Med Sci May 2006 • Vol 22 • No 5 211
Asthma is a common disease characterized by clinical airflow
obstruction that can usually be reversed after a simple
bronchodilator treatment. Many physicians, and even some
patients, tend to view acute exacerbation of this disease as
an annoyance that will pass, rather than a potentially life-
threatening event. Nevertheless, several reports indicate
that asthma mortality has increased during the last few
decades, although the absolute number of deaths is still
relatively small [1–4]. To prevent death from asthma, it is
important to identify patients who are at risk of a fatal
attack. The purpose of this study was to evaluate the clinical
features of fatal asthma and to identify the possible warning
signs associated with a fatal asthma attack.
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To characterize the clinical features of fatal asthma, we retrospectively analyzed the clinical characteristics of
patients who died of an acute asthma attack in our hospital during a 15-year period from 1989 to 2003. Twelve
patients had fatal asthma during this period, including eight who were dead on arrival in the emergency room
(ER) and three who died within 1 hour of admission to the ER. Patients were categorized into three groups
according to the clinical presentations during the fatal attack: (1) rapid (< 3 hours) decompensation in four
patients; (2) gradual development of respiratory failure over several days in two patients; and (3) acute
deterioration after unstable asthma lasting several days in six patients. All patients in groups 1 and 2 had
reported previous near-fatal attacks. The proportion of young patients was highest in group 3, with half of them
(3/6) younger than 35 years of age. Only one patient in group 3 had had a previous near-fatal attack. Five of
the seven patients, with previous near-fatal attacks, had a pattern of decompensation during their fatal attack
that was similar to their previous attacks. In conclusion, nearly all patients with fatal asthma in this study died
outside of the hospital or within 1 hour after admission to the ER. Patients had patterns of decompensation
during the fatal attack that were similar to those of their previous attacks. Early detection of warning signs, early
admission to the ER, adequate treatment, and extremely close observation of patients, especially within 1 hour
after ER arrival, may prevent or decrease the incidence of fatal asthmatic attack.
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PATIENTS AND METHODS
This retrospective study included adult patients (age >15
years) who died of an acute asthma attack during a 15-year
period from January 1989 to December 2003 at National
Cheng Kung University Medical Center, a tertiary-care
medical center in southern Taiwan. Data collected from
medical records included asthma history, date of attack,
and clinical characteristics such as age, gender, duration
between onset of symptoms and fatal attack, patterns of
decompensation, and history of previous admissions due
to near-fatal attacks. Data on parameters associated with
the fatal attack, including blood pressure, heart rate,
respiratory rate, arterial blood gas analysis, and potassium
level were also collected.
We defined patients as having asthma if they had had a
previous diagnosis of asthma by a physician and presented
with at least one of the following two conditions: (1)
subjective evidence of variable wheezing and/or
© 2006 Elsevier. All rights reserved.
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breathlessness and a response to asthma treatment; and (2)
objective evidence of 20% reversibility in peak expiratory
flow recording or forced expiratory volume in 1 second by
spirometry (with 200 mL incremental improvement
following bronchodilator administration). A near-fatal
attack was defined as a severe attack with loss of
consciousness or an attack requiring intubation and
ventilator support.
Patients were divided into three groups according to
their patterns of decompensation during the fatal attack,
using Wasserfallen’s classification [5]. The first group
included patients with an extremely rapid deterioration,
leading to intubation and mechanical ventilation within 3
hours after the onset of the first symptoms. The second
group included patients with gradual decompensation
(crescendo phase), evolving over several days before
institution of mechanical ventilation. The third group
included patients with acute deterioration that occurred
after a few days of unstable asthma. For comparison, the
patterns of decompensation of patients with previous near-
fatal attacks were also studied, noting the duration between
the onset of symptoms and endotracheal intubation or
disturbed consciousness.
RESULTS
Twelve patients had fatal asthma in our hospital from 1989
to 2003. The age range of the patients was 18–89 years (mean
52.1 years). Nine patients (9/12, 75%) were men and three
(3/12, 25%) were women. The average duration between
onset of symptoms and endotracheal intubation was 41
minutes (range, 20–60 min) for patients in group 1 (n = 4),
2 days (range, 1–3 days) in group 2 (n = 2), and 4.9 days
(range, 1–20 days) in group 3 (n = 6). The proportion of
young patients (< 35 years old) was higher among those in
group 3 (3/6, 50%) than among those in group 2 (0/2) and
group 1 (0/4).
Clinical features
All patients had a long history of asthma (mean 25 years,
range 12–40 years). Patients in group 2 had the longest
asthma history (median 29 years, range 17–40 years),
followed by those in group 1 (median 25 years, range 20–30
years) and group 3 (median 24 years, range 12–40 years).
The overall mean number of admissions to the hospital per
subject during the past 12 months was 0.8. All patients in
groups 1 and 2 had one or more near-fatal attacks before
their fatal attacks. The mean number of near-fatal attacks
was 1.5. Six patients had suffered a total of nine previous
near-fatal attacks, and eight of these attacks were severe
enough to require intubation, whereas one had the
manifestation of disturbed consciousness. By contrast, only
one near-fatal attack was noted among patients in group 3,
and the mean number of previous near-fatal attacks was
0.17 (1/6).
Only six of these 12 patients (50%) had regular follow-
up in our outpatient clinic. Seven patients (7/12, 58%) had
previous near-fatal attacks before their fatal attacks. In most
of them (5/7, 71%) the pattern of decompensation during
the fatal attack was similar to that in a previous near-fatal
attack (Table).
Fatal attack features
Eight of the fatal attacks (four patients in group 1 and four
patients in group 3) occurred outside the hospital before
arrival in the emergency room (ER). These patients’ deaths
were considered due to asthma because of histories of
comparable asthma attacks and respiratory failure noted in
their medical records. Among the remaining four cases, the
fatal attack occurred after the patient had arrived in the ER.
Three patients developed respiratory arrest within 1 hour
after arrival. Cardiovascular collapse developed soon after
respiratory arrest, and these patients died despite rapid
intubation and resuscitation. One patient died of asthma
due to a severe attack of asthma during treatment for
asthma in the hospital 3 days after admission. Three of these
four deaths occurred before 1993.
Case presentations
All six patients who had regular follow-up in our outpatient
clinic received treatment with inhaled steroids (equivalent
to beclomethasone 400–1,200 μg/day), short-acting inhaled
`2-bronchodilators, and oral long-acting theophylline
treatment. Two of them had moderate persistent asthma,
and four had severe persistent asthma as defined by GINA
(Global Initiative for Asthma) guideline criteria [6]. Two of
the four patients with severe persistent asthma also received
prednisolone 5–10 mg daily.
Brief histories are given here of four patients who came
to the hospital and then died in the ER or ward.
Case 5
This 78-year-old man had had asthma for 40 years and had
been regularly followed in our hospital for 3 years. He was
treated with inhaled beclomethasone 1,200 μg/day, an oral
long-acting `2-agonist, theophylline, and prednisolone
10 mg daily. However, his asthma was poorly controlled,
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and he had six ER admissions and six hospitalizations in the
3 years before his fatal attack. During his fatal attack he had
gradual decompensation for 2 days, and was admitted to
the general ward. On admission his consciousness was
clear; blood pressure,130/80 mmHg; heart rate, 96 beats/
minute; and respiratory rate, 32 breaths/minute. Arterial
blood gas values were: pH 7.356; PaCO2 60 mmHg; PaO2
46 mmHg; and HCO3
–  34 mEq/L (on nasal cannula oxygen
2 L/min). Nebulized bronchodilators, intravenous
aminophylline, and intravenous methylprednisolone 40
mg were given every 6 hours, but his condition did not
improve. He refused intensive care admission and intubation
with ventilator support because of his having a prolonged
illness. Severe dyspnea with respiratory arrest occurred in
the general ward, followed by cardiovascular collapse on
the second day of hospitalization. Resuscitation was not
successful.
Case 6
A 45-year-old woman had received regular medical
control for allergic asthma for 8 years at our hospital. Her
latest medications were: budesonide 800 μg/day; inhaled
salmeterol 50 mg twice daily; aminophylline 225 mg
twice daily; and fenoterol two inhalations as needed. Her
condition had been stable until she came to the ER this
time because of progressive dyspnea for 1 day after an
upper respiratory infection. On arrival her consciousness
was clear; blood pressure, 161/102 mmHg; heart rate,
160 beats/minute; and respiratory rate, 40 breaths/
minute. Arterial blood gas (on oxygen 2 L/min) values
were: pH 7.240; PaCO2 50.4 mmHg; PaO2 79 mmHg; and
HCO3
– 21.8 mEq/L. Initial treatment included: oxygen;
one inhalation each of nebulized terbutaline and
ipratropium; intravenous hydrocortisone 200 mg; and
aminophylline infusion. However, her condition did not
improve, and respiratory arrest occurred 1 hour after
arrival in the ER. She was intubated, but resuscitation
was not successful.
Case 9
A 55-year-old man had irregular control of asthma. He had
increased dyspnea and wheezing for 1 day, with acute
deterioration about 1 hour before arrival in the ER. On
arrival his consciousness was clear; blood pressure, 102/70
mmHg; heart rate, 96 beats/minute; and respiratory rate, 20
breaths/minute. Arterial blood gases were not measured
because his condition was considered relatively stable.
Initial treatment included: oxygen; one dose of nebulized
Table. Clinical characteristics of patients who died of asthma
Case Date of Age Gender Duration Duration of Pattern of No. of Previous near- Cause of death
attack (yr) of asthma symptom at decompensation previous fatal attack
(yr) fatal attack at fatal attack admissions (date/pattern of
within decompensation)
12 months
1 May 1990 51 F 30 25 min Gr 1 1 Mar 1990/Gr 1 DOA
2 Jan 1992 52 M 20 20 min Gr 1 2 Feb 1990/Gr 2 DOA
3 Nov 1999 70 M 30 < 1 hr Gr 1 1 Feb 1999/Gr 1 DOA
4 July 1995 41 M 20 1 hr Gr 1 0 Sep 1989/Gr 3 DOA
Jan 1990/Gr 1
5 Dec 1991 78 M 40 3 days Gr 2 1 Dec 1989/Gr 2 Cardiopulmonary
Jan 1990/Gr 3    collapse
6 Feb 1998 45 F 17 1 day Gr 2 0 Sep 1994/Gr 1 Cardiopulmonary
Nov 1995/Gr 2    collapse
7 Jun 1989 31 M 12 12 hrs Gr 3 1 Apr 1989/Gr 1 DOA
8 Apr 1994 32 M 19 2 days Gr 3 1 0 DOA
9 Apr 1993 55 M 30 18 hrs Gr 3 0 0 Cardiopulmonary
   collapse
10 May 1991 18 M 14 3 days Gr 3 1 0 Cardiopulmonary
   collapse
11 Feb 2002 62 M 30 20 days Gr 3 1 0 DOA
12 Mar 2002 89 F 40 3 days Gr 3 1 0 DOA
DOA = dead on arrival.
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terbutaline 0.5 mg; and methylprednisolone 40 mg
intravenously. Fenoterol and beclomethasone metered-dose
inhalations were used by the patient in the ER. Unfortunately,
severe dyspnea and respiratory arrest developed suddenly
within 1 hour after arrival in the ER, and resuscitation was
unsuccessful.
Case 10
An 18-year-old man had no history of regular medical
treatment for asthma. He had had an acute attack about 2
hours before arrival in the ER. On arrival in the ER his vital
signs were: blood pressure, 120/70 mmHg; heart rate, 112
beats/minute; and respiratory rate, 38 breaths/minute.
Initial treatment included: oxygen; subcutaneous
epinephrine 0.3 mg;  three doses nebulized terbutaline 0.5
mg at 20-minute intervals; and intravenous hydrocortisone
200 mg. After the treatment, arterial blood gases were pH
7.051 and PaCO2 84.9 mmHg. Intubation was performed
about 1 hour after ER admission. Persistent cyanosis,
bradycardia, and hypotension developed, and he died 2
hours later.
DISCUSSION
In most cases of severe life-threatening asthma, the attack
develops against a background of poorly controlled disease.
However, in 10–20% of cases of fatal or near-fatal asthma,
the onset seems to be sudden and unexpected, with death
sometimes occurring within a few hours. These episodes
have been termed “sudden asphyxic asthma” [5]. The
duration of these fatal attacks can be extremely short, and
patients frequently die outside of the hospital—sometimes
before they can call for medical help [5,7–9].
In this study of 12 patients with fatal asthma, four
patients suffered from sudden asphyxic attacks (group 1).
They presented with rapid progressive deterioration, leading
to acute respiratory failure within 3 hours of the onset of
symptoms. The average duration of the fatal attack was 41
minutes, and ranged from 20 minutes to 1 hour. All four
patients died outside of the hospital. It is difficult to
prevent death from sudden asphyxic asthma, either
because the fatal attacks are so sudden and progress so
rapidly that appropriate medical help cannot be summoned
in time, or because there is an unavoidable delay in the
arrival of help [1]. Educating patients, who are at risk of
fatal attacks, and their families in the use of subcutaneous
epinephrine may be the only method to prevent fatalities
from these attacks [10].
Two reports show that more airway remodeling, more
bronchoconstriction, and more mucus plugs in submucosal
glands are found in patients with fatal asthma than in those
with nonfatal asthma [11,12]. More bronchoconstriction is
noted in short-course (< 3 hours) fatal asthma, whereas
more mucus accumulation is found in long-course (> 8
hours) fatal asthma [11]. Retrospective analyses have also
highlighted several clinical characteristics of patients who
died of asthma [13–18]. Crane et al  reported that a history
of admission for asthma in the preceding 12 months was the
strongest single indicator of risk for subsequent death from
asthma [14], whereas Rea et al reported that a history of a
near-fatal attack that required hospitalization and
mechanical ventilation was the strongest single predictor of
subsequent fatal attack [16]. All four patients who died
from sudden asphyxic asthma had these two important
clinical characteristics. Most of them had a history of
admission for asthma in the preceding 12 months, and all of
them had a history of a near-fatal attack. We also found that
the patterns of decompensation in previous near-fatal attacks
and fatal attacks were similar in these patients.
A previous  s tudy suggested  that  reduced
chemosensitivity to hypoxia and blunted perception of
dyspnea may predispose patients to fatal asthmatic attacks
[19]. This may explain why these patients experienced a
relatively mild or asymptomatic state of asthma until
minutes or a few hours before their death. Measurements of
airway narrowing, such as peak-flow monitoring, are
required to assess a patient’s actual condition. Thus,
identification of high-risk patients who have a history of a
near-fatal attack of sudden asphyxic asthma and early
detection of an unstable condition by peak-flow meter are
essential.
Inadequate assessment, observation, and treatment have
also been reported as contributors to fatal asthma attacks
[1,17,18,]. Two patients in our study suffered from
progressive deterioration over several days (group 2). One
of these patients developed respiratory arrest about 1 hour
after her arrival in the ER, whereas the other developed
respiratory arrest in the general ward 3 days after admission.
Both patients died soon after the onset of respiratory arrest,
despite intubation and resuscitation. Inadequate close
observation and delayed intubation were considered to
contribute to the death of these two patients.
A history of recent admission for asthma and near-fatal
attack seems to be an important risk factor for fatal asthma
attack [18]. Among the six patients with acute deterioration
after unstable asthma (group 3), 50% (3/6) were younger
than 35 years of age, and 5 had had no previous near-fatal
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attacks. Among these six patients, the mean duration of
symptoms was 4.9 days. Four of these patients died outside
the hospital, and two died within 1 hour after arrival in the
ER. One of these two patients had not received adequate
treatment, because the severity of the asthma was
underestimated. The other patient had disturbed
consciousness on arrival, and sudden respiratory and
cardiopulmonary arrest developed soon thereafter. To
prevent death in patients such as these, adequate assessment
and treatment, careful monitoring of the response to medical
treatment, and early intubation with ventilator support are
essential soon after admission to the ER. It should be
mentioned that three of the four patient deaths in the ER
occurred before 1993, when GINA and Heart Lung and
Blood Institutes asthma management guidelines were not
yet available.
In conclusion, nearly all patients with fatal asthma in
this study died outside of the hospital or within 1 hour after
admission to the ER. A history of a near-fatal attack should
be considered a warning sign that a similar life-threatening
attack may recur. Some fatal attacks occurred without a
previous episode of severe attack, and these fatal attacks
were more frequent in younger patients. Better patient
education for management of acute attacks, especially for
high-risk patients, and better physician training in the
management and close observation of these patients in the
ER, especially during the first hour, may prevent or reduce
fatal asthmatic attacks.
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